Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 12Dr. Reddy's Laboratories
03 4Breckenridge Pharmaceutical
04 4Ever Pharma
05 12Accord healthcare
06 4Anabiosis S.A.
07 8Apotex Inc
08 4Aurobindo Pharma Limited
09 4Avansor Pharma Oy
10 4BASI
11 3Bioglan
12 4Bristol Laboratories Ltd
13 23Bristol Myers Squibb
14 8Celgene Corporation
15 4Cipla Medpro South Africa
16 8Day Zero Ehf
17 4Deva Holding AS
18 2Eurolab
19 2Farmoz Sociedade Tecnico Medicinal Sa
20 4GSK
21 8Grindeks AS
22 4Hetero Drugs
23 4JAMP PHARMA
24 16Juno Pharmaceuticals Pty Ltd
25 4Key Oncologics
26 8Krka
27 4Laboratorio Eczane Pharma
28 4Natco Pharma (Canada) Inc
29 4Newbury Pharmaceuticals Ab
30 4Pinnacle Life Science
31 2Reig Jofre
32 8STADA Arzneimittel
33 1Sakar Healthcare
34 28Sandoz B2B
35 4Spirig Healthcare
36 4Tecnimede
37 18Teva Pharmaceutical Industries
38 15Viatris
39 4XYZ Pharma
40 4Zentiva
01 10CAP
02 24CAPSULE
03 32CAPSULE;ORAL
04 83Capsule
05 4Capsule, hard
06 5Capsules
07 68Hard Capsule
08 4Oral Solid Dosage Form
09 1Pomalidomide 1Mg 21 Combined Oral Use
10 1Pomalidomide 2Mg 21 Combined Oral Use
11 1Pomalidomide 3Mg 21 Combined Oral Use
12 1Pomalidomide 4Mg 21 Combined Oral Use
13 12capsule
14 24Blank
01 32Allowed
02 71Approved
03 36Authorized
04 24DISCN
05 6Generic
06 4Lead Market Dossiers- Filed
07 4Lead Market Dossiers- Tentative\nApproved in US
08 4Originator
09 24Prescription
10 4RX
11 61Blank
01 4APO-POMALIDOMIDE
02 4Davunfite
03 19Imnovid
04 1Imnovid 1 mg
05 1Imnovid 2 mg
06 1Imnovid 3 mg
07 1Imnovid 4 mg
08 4JAMP POMALIDOMIDE
09 4NAT-POMALIDOMIDE
10 28POMALIDOMIDE
11 8POMALYST
12 4Pomalidomid Avansor
13 4Pomalidomid Devatis
14 4Pomalidomida Accord
15 4Pomalidomida Eczane
16 4Pomalidomida Erawya
17 4Pomalidomida Grindeks
18 4Pomalidomida Krka
19 2Pomalidomida Sala
20 4Pomalidomida Stada
21 2Pomalidomida Teva
22 4Pomalidomide
23 1Pomalidomide 1 mg Cipla
24 1Pomalidomide 2 mg Cipla
25 1Pomalidomide 3 mg Cipla
26 1Pomalidomide 4 mg Cipla
27 8Pomalidomide Accord
28 4Pomalidomide Anabiosis
29 3Pomalidomide Bioglan
30 4Pomalidomide Ever Pharma
31 4Pomalidomide Glenmark
32 4Pomalidomide Grindeks
33 4Pomalidomide Krka
34 4Pomalidomide Newbury
35 24Pomalidomide Sandoz
36 4Pomalidomide Spirig HC
37 4Pomalidomide Stada
38 2Pomalidomide Tecnogen
39 4Pomalidomide Teva
40 11Pomalidomide Viatris
41 8Pomalidomide Zentiva
42 4Pomalidomide-Teva
43 4Pomalidomide-Teva Mepha
44 8Pomalyst
45 1Pomaxel 3 mg
46 1Pomaxel 4 mg
47 16Pomolide
48 4REDDY-POMALIDOMIDE
49 4SANDOZ POMALIDOMIDE
50 4Sulabcote
51 13Blank
01 4Argentina
02 36Australia
03 24Canada
04 13India
05 4Italy
06 4Norway
07 4Portugal
08 10South Africa
09 36Spain
10 71Sweden
11 32Switzerland
12 32USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 1mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pomalidomide Ever Pharma
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 18/12/2024
Application Number : 20230928000125
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 2mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 3mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 4mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 2504073
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 2504081
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 2504103
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2504111
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Contact Us!
